Sajjad A, Hameed S, Khan S
Pak J Med Sci. 2024; 40(8):1669-1674.
PMID: 39281214
PMC: 11395352.
DOI: 10.12669/pjms.40.8.7719.
Zhu W, Da Y, Chen H, Xu M, Lu Y, Di L
World J Clin Cases. 2022; 10(5):1709-1715.
PMID: 35211613
PMC: 8855276.
DOI: 10.12998/wjcc.v10.i5.1709.
Mahdi-Rogers M, Brassington R, Gunn A, van Doorn P, Hughes R
Cochrane Database Syst Rev. 2017; 5:CD003280.
PMID: 28481421
PMC: 6481566.
DOI: 10.1002/14651858.CD003280.pub5.
Lunn M, Nobile-Orazio E
Cochrane Database Syst Rev. 2016; 10:CD002827.
PMID: 27701752
PMC: 6457998.
DOI: 10.1002/14651858.CD002827.pub4.
Dimachkie M, Barohn R, Katz J
Neurol Clin. 2013; 31(2):533-55.
PMID: 23642723
PMC: 4098937.
DOI: 10.1016/j.ncl.2013.01.001.
Chronic inflammatory demyelinating polyneuropathy.
Dimachkie M, Barohn R
Curr Treat Options Neurol. 2013; 15(3):350-66.
PMID: 23564314
PMC: 3987657.
DOI: 10.1007/s11940-013-0229-6.
Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K, van Doorn P
Drugs. 2009; 69(8):987-1001.
PMID: 19496628
DOI: 10.2165/00003495-200969080-00004.
Inflammatory demyelinating neuropathies.
Muley S, Parry G
Curr Treat Options Neurol. 2009; 11(3):221-7.
PMID: 19364457
DOI: 10.1007/s11940-009-0026-4.
Chronic Inflammatory Demyelinating Polyneuropathy.
Katz J, Saperstein D
Curr Treat Options Neurol. 2003; 5(5):357-364.
PMID: 12895398
DOI: 10.1007/s11940-003-0026-8.
Management of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes R
Drugs. 2003; 63(3):275-87.
PMID: 12534332
DOI: 10.2165/00003495-200363030-00003.
Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
Saperstein D, Barohn R
Curr Neurol Neurosci Rep. 2003; 3(1):57-63.
PMID: 12507413
DOI: 10.1007/s11910-003-0039-4.
Chronic Inflammatory Demyelinating Polyneuropathy.
Gorson , Chaudhry V
Curr Treat Options Neurol. 2000; 1(3):251-262.
PMID: 11096713
DOI: 10.1007/s11940-999-0007-7.
Treatment of chronic inflammatory demyelinating polyneuropathy.
Comi G, Roveri L
Ital J Neurol Sci. 2000; 19(5):261-9.
PMID: 10933445
DOI: 10.1007/BF00713851.
A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Thompson N, Choudhary P, Hughes R, Quinlivan R
J Neurol. 1996; 243(3):280-5.
PMID: 8936360
DOI: 10.1007/BF00868527.
Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A.
Mahattanakul W, Crawford T, Griffin J, Goldstein J, Cornblath D
J Neurol Neurosurg Psychiatry. 1996; 60(2):185-7.
PMID: 8708650
PMC: 1073801.
DOI: 10.1136/jnnp.60.2.185.
IgG monoclonal paraproteinaemia and peripheral neuropathy.
Bleasel A, Hawke S, Pollard J, McLeod J
J Neurol Neurosurg Psychiatry. 1993; 56(1):52-7.
PMID: 8381472
PMC: 1014766.
DOI: 10.1136/jnnp.56.1.52.
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Faulds D, Goa K, Benfield P
Drugs. 1993; 45(6):953-1040.
PMID: 7691501
DOI: 10.2165/00003495-199345060-00007.